Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Supernus Pharmaceuticals Inc’s current trading price is -16.78% away from its 52-week high, while its distance from the 52-week low
Supernus Pharmaceuticals Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $39.37 on 11/05/24, while the lowest price for the same period was registered at $25.53 on 06/14/24. 52-week price history of SUPN Stock Studying a
Qelbree, a drug developed by Supernus Pharmaceuticals, Inc. (SUPN), recently received FDA approval. Consequently, SUPN shares traded at 30.11 USD on April 5th for a gain of 12.7%. Qelbree is specifically approved to treat attention deficit hyperactivity disorder in patients between the ages of 6
All rights reserved © 2024, Powered By Smart TechOne
